JUVMO

Product NDC
0074-5925
11-digit product format
000745925
Labeler code
0074
Product ID
0074-5925_1cbfaa3b-d541-4ac3-bf4e-9ab82d8d1b6c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tavapadon
Dosage form
TABLET
Route
ORAL
Labeler
AbbVie Inc.
Application
NDA220415
Marketing category
NDA
Marketing start
2026-09-25
Substance
TAVAPADON
Active strength
.25 mg/1
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N220415-001JUVMO (COPACKAGED)TAVAPADON0.25MG;1MGTABLET / ORALRLD, RS2026-09-25
N220415-002JUVMOTAVAPADON5MGTABLET / ORALRLD, RS2026-09-25
N220415-003JUVMOTAVAPADON10MGTABLET / ORALRLD2026-09-25
N220415-004JUVMOTAVAPADON15MGTABLET / ORALRLD2026-09-25

Orange Book patents#

Current patent rows page 1 of 1 · 16 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N220415-001100936552034-06-23U-2192026-10-22
N220415-001104217442034-06-23U-2192026-10-22
N220415-00191079232034-06-23Drug substance, Drug product2026-10-22
N220415-00195278312034-06-23Drug substance, Drug product2026-10-22
N220415-002100936552034-06-23U-2192026-10-22
N220415-002104217442034-06-23U-2192026-10-22
N220415-00291079232034-06-23Drug substance, Drug product2026-10-22
N220415-00295278312034-06-23Drug substance, Drug product2026-10-22
N220415-003100936552034-06-23U-2192026-10-22
N220415-003104217442034-06-23U-2192026-10-22
N220415-00391079232034-06-23Drug substance, Drug product2026-10-22
N220415-00395278312034-06-23Drug substance, Drug product2026-10-22
N220415-004100936552034-06-23U-2192026-10-22
N220415-004104217442034-06-23U-2192026-10-22
N220415-00491079232034-06-23Drug substance, Drug product2026-10-22
N220415-00495278312034-06-23Drug substance, Drug product2026-10-22

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 4 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
N220415-001NCE2031-09-25
N220415-002NCE2031-09-25
N220415-003NCE2031-09-25
N220415-004NCE2031-09-25

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N220415-001JUVMO (COPACKAGED)0.25MG;1MGTABLET / ORALRLD, RS2026-09-25d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-002JUVMO5MGTABLET / ORALRLD, RS2026-09-25d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-003JUVMO10MGTABLET / ORALRLD2026-09-25d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-004JUVMO15MGTABLET / ORALRLD2026-09-25d4dbc9d85df4…
2026-10-15 13:18:302026-09N220415-001JUVMO (COPACKAGED)0.25MG;1MGTABLET / ORALRLD2026-09-25c2088c7a36db…
2026-10-15 13:18:302026-09N220415-002JUVMO5MGTABLET / ORALRLD2026-09-25c2088c7a36db…
2026-10-15 13:18:302026-09N220415-003JUVMO10MGTABLET / ORALRLD2026-09-25c2088c7a36db…
2026-10-15 13:18:302026-09N220415-004JUVMO15MGTABLET / ORALRLD, RS2026-09-25c2088c7a36db…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-11-14 07:37:172026-10N220415-001100936552034-06-23U-2192026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-001104217442034-06-23U-2192026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-00191079232034-06-23Drug substance, Drug product2026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-00195278312034-06-23Drug substance, Drug product2026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-002100936552034-06-23U-2192026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-002104217442034-06-23U-2192026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-00291079232034-06-23Drug substance, Drug product2026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-00295278312034-06-23Drug substance, Drug product2026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-003100936552034-06-23U-2192026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-003104217442034-06-23U-2192026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-00391079232034-06-23Drug substance, Drug product2026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-00395278312034-06-23Drug substance, Drug product2026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-004100936552034-06-23U-2192026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-004104217442034-06-23U-2192026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-00491079232034-06-23Drug substance, Drug product2026-10-22d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-00495278312034-06-23Drug substance, Drug product2026-10-22d4dbc9d85df4…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-11-14 07:37:172026-10N220415-001NCE2031-09-25d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-002NCE2031-09-25d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-003NCE2031-09-25d4dbc9d85df4…
2026-11-14 07:37:172026-10N220415-004NCE2031-09-25d4dbc9d85df4…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
JUVMO
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TAVAPADON.25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
PT4P8MJP8LInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 12 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2754365Internal RxNorm lookup
2754371Internal RxNorm lookup
2754373Internal RxNorm lookup
2754375Internal RxNorm lookup
2754377Internal RxNorm lookup
2754379Internal RxNorm lookup
2754381Internal RxNorm lookup
2754383Internal RxNorm lookup
2754385Internal RxNorm lookup
2754387Internal RxNorm lookup
2754388Internal RxNorm lookup
2754389Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1ae6df6e-6ca0-420f-bec9-effa7acdd085Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JUVMOTAVAPADONAbbVie Inc.1ae6df6e-6ca0-420f-bec9-effa7acdd0852026-10-08Warnings, Adverse reactionsExact identifier
application applno (NDA): 220415
application number: NDA220415
ndc (product): 0074-5925

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0074-5925-210007459252121 TABLET in 1 BLISTER PACK (0074-5925-21) 21 tablet2026-09-25YesNoCurrent